PILRB (Paired Immunoglobulin-like Type 2 Receptor Beta) encodes a membrane protein involved in immune cell signaling. While primarily studied in natural killer cells and macrophages, PILRB has emerging roles in neuroinflammation and neurodegenerative disease pathogenesis["@satoh2006"].
Gene Information
Protein Structure
PILRB contains several key structural features:
Ig-like domains: Two immunoglobulin-like domains for receptor binding
Transmembrane region: Single pass membrane-spanning domain
ITIM motifs: Immunoreceptor tyrosine-based inhibition motifs in cytoplasmic tail
The presence of ITIM motifs suggests an inhibitory function in immune cell signaling[@kogelman2017].
Biological Functions
PILRB performs important immune regulatory functions:
Immune receptor signaling: Modulates activation and inhibition pathways
NK cell regulation: Controls natural killer cell activity through inhibitory signaling
Macrophage activation: Influences phagocytic activity and cytokine production
Cell-cell communication: Mediates interactions between immune cells
Expression Pattern
PILRB is expressed primarily in immune cells:
Natural killer cells: High expression on NK cell surfaces
Macrophages: Modulates phagocytic activity
Dendritic cells: Regulates antigen presentation
Brain: Microglial expression
In the brain, PILRB is primarily expressed on microglial cells, the resident immune cells of the central nervous system.
Role in Neurodegeneration
PILRB contributes to neurodegenerative diseases through neuroinflammatory mechanisms:
Microglial Activation
PILRB influences brain immune cell function:
Regulates microglial activation states
Modulates inflammatory responses to injury
Affects cytokine and chemokine production
Controls phagocytic clearance mechanisms
Immune-Brain Interaction
The receptor mediates crosstalk between peripheral immune system and brain:
Peripheral immune to brain communication pathways
Inflammatory signaling across the [blood-brain barrier](/entities/blood-brain-barrier)
Clearance mechanisms for pathological proteins
Alzheimer's Disease
PILRB may contribute to AD pathogenesis through:
Modulation of microglial responses to [amyloid-beta](/proteins/amyloid-beta)
Regulation of chronic neuroinflammation
Potential effects on [tau](/proteins/tau) pathology
Parkinson's Disease
In PD:
Regulation of dopaminergic neuron-immune interactions
Microglial activation in substantia nigra
Neuroinflammation in disease progression
Disease Associations
Interacting Partners
PILRB interacts with several signaling proteins:
Therapeutic Potential
PILRB offers several therapeutic opportunities:
Targeting neuroinflammation: Modulating microglial activation states
Peripheral immune modulation: Affecting brain-immune communication
Phagocytosis enhancement: Improving clearance of pathological proteins
Combination approaches: With other immunomodulatory strategies